All news

Mcdonald Capital trims Regeneron stake by 10.6%

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Mcdonald Capital Investors Inc. CA cut its Regeneron Pharmaceuticals (NASDAQ:REGN) stake by 10.6% in the third quarter, selling 20,389 shares, while still holding 172,649 shares valued at

Read original source

REGN company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.